以代谢组学为基础的营养产品市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

2024 年全球代谢组学营养产品市场价值为 28 亿美元，预计到 2034 年将以 23.3% 的复合年增长率成长至 272 亿美元。

市场成长的主要驱动力是消费者对专业代谢组学补充剂和特定疾病配方的需求不断增长，以及维生素和氨基酸产品在精准营养应用中的广泛应用。代谢组学分析技术的进步使得个人化营养策略得以实现，而临床研究也不断验证标靶健康干预措施的有效性。美国食品药物管理局（FDA）的监管指导以及个人化营养在医疗保健、生物技术和健康领域的日益普及，进一步推动了市场扩张。新一代代谢组学产品能够无缝融入治疗药物的研发，提供可扩展、安全有效的生物活性化合物。这些创新正在精准营养领域创造商业规模的机会，拓展专业补充剂、多生物标记技术和生物标誌物驱动配方的应用范围，同时也促进了基于代谢组学的方法在专业营养和健康计划中的更广泛应用。

2024年，专业代谢组学补充剂市场规模达9.98亿美元，预计到2034年将以25.7%的复合年增长率成长，占据35%的市场份额。此细分市场的成长得益于补充剂设计的创新、其在精准营养应用领域的广泛适用性以及强大的生物标记验证框架。这些补充剂能够实现可扩展的分子谱分析和生物活性成分优化，从而在研究、中试和商业生产环境中建立了稳定的需求。

2024年，个人化和精准营养市场规模达到11亿美元，预计2034年将以27.1%的复合年增长率成长。其成长得益于个人化营养分析技术的进步、健康优化方案的多样化以及代谢组学标准的验证。可扩展的分析方法能够精准识别干预措施后的代谢反应，从而满足临床、研究和商业健康领域持续增长的需求。

预计到2024年，美国基于代谢组学的营养产品市场规模将达到10亿美元，占80%的市场。这一市场主导地位得益于政府推动精准营养研究的倡议、先进的代谢组学基础设施以及行业领导者的参与。美国食品药物管理局（FDA）的膳食补充剂指南、个人化营养法规以及代谢组学分析技术的创新共同塑造了这个市场。采购和供应商标准与临床试验框架和生物标记验证方案一致，从而维持了下游对基于先进代谢组学的产品在个人化健康和精准营养应用领域的需求。

全球代谢体学营养产品市场的主要参与者包括：Life Extension、Thorne Health、Metagenics、Designs for Health、Pure Encapsulations、Douglas Laboratories、Jarrow Formulas、Cambridge Isotope Laboratories、Sigma-Aldrich（Mock）、NOW Foods、Integrative Therapu​​yative Thegrative The​​an Z​​amps（Makun​​yk、Awilla 你） Labs）、Nutricology、Biotics Research、Vital Nutrients、Protocol for Life Balance、Researched Nutritionals、Apex Energetics、Bioclinic Naturals、Quicksilver Scientific 和 Seeking Health。这些公司正采取多种策略来巩固其市场地位。他们大力投资研发，以增强代谢组学分析能力、优化生物活性成分的鑑定，并开发多生物标记配方。策略合作与伙伴关係使企业能够拓展产品组合併进入新市场。各公司正优先考虑临床验证和监管合规性，以增强产品的可信度。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

• 产业生态系分析
  • 供应商格局
  • 利润率
  • 每个阶段的价值增加
  • 影响价值链的因素
  • 中断
• 产业影响因素
  • 司机
  • 陷阱与挑战
  • 机会
• 成长潜力分析
• 监管环境
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
• 波特的分析
• PESTEL 分析
• 价格趋势
  • 按地区
  • 依产品类型
• 未来市场趋势
• 技术与创新格局
  • 当前技术趋势
  • 新兴技术
• 专利格局
• 贸易统计（HS编码）（註：仅提供重点国家的贸易统计资料）
  • 主要进口国
  • 主要出口国
• 永续性和环境方面
  • 永续实践
  • 减少废弃物策略
  • 生产中的能源效率
  • 环保倡议
• 碳足迹考量

第四章：竞争格局

• 介绍
• 公司市占率分析
  • 按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • MEA
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 合作伙伴关係与合作
  • 新产品发布
  • 扩张计划

第五章：市场估算与预测：依产品类型划分，2021-2034年

• 主要趋势
• 维生素及相关补充剂
  • 脂溶性维生素
    • 维生素A（视黄醇/β-胡萝卜素）
    • 维生素D3（胆钙化醇）
    • 维生素E（生育酚/生育三烯酚）
    • 维生素K2（甲萘醌）
  • 水溶性维生素
    • 叶酸/维生素B9
    • 维生素B12（钴胺素/甲基钴胺素）
    • 维生素B6（吡哆醇/磷酸吡哆醛）
    • 其他B群维生素（B1、B2、B3、B5、B7）
• 矿物质和微量元素补充剂
  • 必需矿物质
  • 微量元素
• 胺基酸和蛋白质相关补充剂
  • 支链胺基酸（BCAA）
  • 必需胺基酸
  • 非必需胺基酸
  • 胺基酸衍生物
• 脂肪酸补充剂
  • ω-3多元不饱和脂肪酸
  • 其他脂肪酸
• 抗氧化剂和植物化学补充剂
  • 富含多酚的萃取物
  • 类胡萝卜素
  • 特化抗氧化剂
• 益生元和益生菌补充剂
  • 益生元纤维
  • 益生菌菌株
• 专门的代谢组学补充剂
  • 粒线体支持
  • 甲基化支持
  • 神经传导物质前驱物
• 针对特定病症的配方
  • 代谢症候群支持
  • 心血管健康
  • 肝臟健康

第六章：市场估算与预测：依应用领域划分，2021-2034年

• 主要趋势
• 个人化/精准营养
• 临床和健康应用
• 功能性食品及营养保健品开发
• 针对微生物组的应用

第七章：市场估计与预测：依配销通路划分，2021-2034年

• 主要趋势
  • 直接面向消费者（DTC）
  • 电子商务网站
  • 行动应用
  • 居家采集套装
  • 其他的
• 医疗保健和临床频道
  • 医生和临床医生
  • 註册营养师
  • 功能医学从业人员
  • 医院实验室
  • 其他的
• 零售和药房管道
  • 健康食品店
  • 药局
  • 超市和大型超市
  • 其他的
• 专业和 B2B 频道
  • 大学和研究中心
  • 政府研究机构
  • 营养保健品生产商
  • 合约製造组织
  • 其他的
• 数位化与技术赋能管道
  • 生物资讯服务
  • 人工智慧平台
  • 多组学平台
  • 其他的

第八章：市场估算与预测：依地区划分，2021-2034年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第九章：公司简介

• Thorne Health
• Life Extension
• Metagenics
• Douglas Laboratories
• Designs for Health
• Pure Encapsulations
• Jarrow Formulas
• Cambridge Isotope Laboratories
• Sigma-Aldrich (Merck)
• NOW Foods
• Cayman Chemical
• Integrative Therapeutics
• XYMOGEN
• Ortho Molecular Products
• Allergy Research Group
• SFI Health (Klaire Labs)
• Nutricology
• Biotics Research
• Vital Nutrients
• Protocol for Life Balance
• Researched Nutritionals
• Apex Energetics
• Bioclinic Naturals
• Quicksilver Scientific
• Seeking Health

The Global Metabolomics-based Nutritional Products Market was valued at USD 2.8 billion in 2024 and is estimated to grow at a CAGR of 23.3% to reach USD 27.2 billion by 2034.

The market growth is primarily driven by increasing demand for specialized metabolomic supplements and condition-specific formulations, alongside the broader adoption of vitamin- and amino acid-based products in precision nutrition applications. Advances in metabolomic profiling enable more personalized nutrition strategies, while clinical research continues to validate targeted health interventions. Regulatory guidance from the FDA and growing adoption of personalized nutrition in healthcare, biotechnology, and wellness sectors further reinforce market expansion. Next-generation metabolomic products integrate seamlessly into therapeutic development, delivering scalable, safe, and effective bioactive compounds. These innovations are creating commercial-scale opportunities in precision nutrition, expanding applications for specialized supplements, multi-biomarker technologies, and biomarker-driven formulations, while enabling wider acceptance of metabolomics-based approaches in specialty nutrition and wellness initiatives.

The specialized metabolomic supplements segment was valued at USD 998 million in 2024 and is projected to grow at a CAGR of 25.7% through 2034, accounting for a 35% share of the market. The segment's growth is fueled by innovations in supplement design, its versatility across precision nutrition applications, and robust biomarker validation frameworks. These supplements allow scalable molecular profiling and bioactive component optimization, establishing steady demand across research, pilot, and commercial production environments.

The personalized and precision nutrition segment generated USD 1.1 billion in 2024 and is anticipated to grow at a CAGR of 27.1% through 2034. Its growth is supported by advancements in individualized nutritional profiling, versatility in health optimization, and validated metabolomic standards. Scalable profiling enables precise identification of metabolic responses to interventions, supporting consistent demand across clinical, research, and commercial wellness environments.

U.S. Metabolomics-based Nutritional Products Market was valued at USD 1 billion in 2024, accounting for an 80% share. This dominance is supported by government initiatives promoting precision nutrition research, advanced metabolomics infrastructure, and the presence of leading industry players. The market is shaped by FDA dietary supplement guidelines, personalized nutrition regulations, and innovations in metabolomic profiling technologies. Procurement and supplier standards are aligned with clinical trial frameworks and biomarker validation protocols, sustaining downstream demand for advanced metabolomics-based products in both personalized wellness and precision nutrition applications.

Key players in the Global Metabolomics-based Nutritional Products Market include Life Extension, Thorne Health, Metagenics, Designs for Health, Pure Encapsulations, Douglas Laboratories, Jarrow Formulas, Cambridge Isotope Laboratories, Sigma-Aldrich (Merck), NOW Foods, Integrative Therapeutics, XYMOGEN, Ortho Molecular Products, Allergy Research Group, SFI Health (Klaire Labs), Nutricology, Biotics Research, Vital Nutrients, Protocol for Life Balance, Researched Nutritionals, Apex Energetics, Bioclinic Naturals, Quicksilver Scientific, and Seeking Health. Companies in the Metabolomics-based Nutritional Products Market are pursuing several strategies to strengthen their market position. They are heavily investing in research and development to enhance metabolomic profiling capabilities, optimize bioactive component identification, and develop multi-biomarker formulations. Strategic collaborations and partnerships allow firms to expand product portfolios and access new markets. Companies are prioritizing clinical validation and regulatory compliance to reinforce product credibility.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Product type trends
  • 2.2.2 Application trends
  • 2.2.3 Distribution channel trends
  • 2.2.4 Regional trends
• 2.3 TAM Analysis, 2025-2034
• 2.4 CXO perspectives: Strategic imperatives
  • 2.4.1 Executive decision points
  • 2.4.2 Critical success factors
• 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Drivers
  • 3.2.2 Pitfalls & Challenges
  • 3.2.3 Opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
• 3.7 Price trends
  • 3.7.1 By region
  • 3.7.2 By product type
• 3.8 Future market trends
• 3.9 Technology and Innovation landscape
  • 3.9.1 Current technological trends
  • 3.9.2 Emerging technologies
• 3.10 Patent Landscape
• 3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries
• 3.12 Sustainability and environmental aspects
  • 3.12.1 Sustainable practices
  • 3.12.2 Waste reduction strategies
  • 3.12.3 Energy efficiency in production
  • 3.12.4 Eco-friendly initiatives
• 3.13 Carbon footprint consideration

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New Product Launches
  • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021-2034 (USD Million & Units)

• 5.1 Key trends
• 5.2 Vitamin and vitamin-related supplements
  • 5.2.1 Fat-soluble vitamins
    • 5.2.1.1 Vitamin A (retinol/Beta-carotene)
    • 5.2.1.2 Vitamin D3 (cholecalciferol)
    • 5.2.1.3 Vitamin E (tocopherols/tocotrienols)
    • 5.2.1.4 Vitamin K2 (menaquinone)
  • 5.2.2 Water-soluble vitamins
    • 5.2.2.1 Folate/Folic Acid (B9)
    • 5.2.2.2 Vitamin B12 (cobalamin/methylcobalamin)
    • 5.2.2.3 Vitamin B6 (pyridoxine/pyridoxal-5-phosphate)
    • 5.2.2.4 Other B vitamins (B1, B2, B3, B5, B7)
• 5.3 Mineral and trace element supplements
  • 5.3.1 Essential minerals
  • 5.3.2 Trace elements
• 5.4 Amino acid and protein-related supplements
  • 5.4.1 Branched-chain amino acids (BCAAs)
  • 5.4.2 Essential amino acids
  • 5.4.3 Non-essential amino acids
  • 5.4.4 Amino acid derivatives
• 5.5 Fatty acid supplements
  • 5.5.1 Omega-3 polyunsaturated fatty acids
  • 5.5.2 Other fatty acids
• 5.6 Antioxidant and phytochemical supplements
  • 5.6.1 Polyphenol-rich extracts
  • 5.6.2 Carotenoids
  • 5.6.3 Specialized antioxidants
• 5.7 Prebiotic and probiotic supplements
  • 5.7.1 Prebiotic fibers
  • 5.7.2 Probiotic strains
• 5.8 Specialized metabolomic supplements
  • 5.8.1 Mitochondrial support
  • 5.8.2 Methylation support
  • 5.8.3 Neurotransmitter precursors
• 5.9 Condition-specific formulations
  • 5.9.1 Metabolic syndrome support
  • 5.9.2 Cardiovascular health
  • 5.9.3 Liver health

Chapter 6 Market Estimates and Forecast, By Application, 2021-2034 (USD Million & Units)

• 6.1 Key trends
• 6.2 Personalized/precision nutrition
• 6.3 Clinical and health applications
• 6.4 Functional food and nutraceutical development
• 6.5 Microbiome-targeted applications

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021-2034 (USD Million & Units)

• 7.1 Key trends
  • 7.1.1 Direct-to-consumer (DTC)
  • 7.1.2 E-commerce websites
  • 7.1.3 Mobile applications
  • 7.1.4 At-home collection kits
  • 7.1.5 Others
• 7.2 Healthcare and clinical channels
  • 7.2.1 Physicians and clinicians
  • 7.2.2 Registered dietitians
  • 7.2.3 Functional medicine practitioners
  • 7.2.4 Hospital-based labs
  • 7.2.5 Others
• 7.3 Retail and pharmacy channels
  • 7.3.1 Health food stores
  • 7.3.2 Pharmacies
  • 7.3.3 Supermarkets & hypermarkets
  • 7.3.4 Others
• 7.4 Professional and b2b channels
  • 7.4.1 Universities and research centers
  • 7.4.2 Government research facilities
  • 7.4.3 Nutraceutical manufacturers
  • 7.4.4 Contract manufacturing organizations
  • 7.4.5 Others
• 7.5 Digital and technology-enabled channels
  • 7.5.1 Bioinformatics services
  • 7.5.2 Ai-powered platforms
  • 7.5.3 Multi-omics platforms
  • 7.5.4 Others

Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 (USD Million & Units)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Thorne Health
• 9.2 Life Extension
• 9.3 Metagenics
• 9.4 Douglas Laboratories
• 9.5 Designs for Health
• 9.6 Pure Encapsulations
• 9.7 Jarrow Formulas
• 9.8 Cambridge Isotope Laboratories
• 9.9 Sigma-Aldrich (Merck)
• 9.10 NOW Foods
• 9.11 Cayman Chemical
• 9.12 Integrative Therapeutics
• 9.13 XYMOGEN
• 9.14 Ortho Molecular Products
• 9.15 Allergy Research Group
• 9.16 SFI Health (Klaire Labs)
• 9.17 Nutricology
• 9.18 Biotics Research
• 9.19 Vital Nutrients
• 9.20 Protocol for Life Balance
• 9.21 Researched Nutritionals
• 9.22 Apex Energetics
• 9.23 Bioclinic Naturals
• 9.24 Quicksilver Scientific
• 9.25 Seeking Health